The company intends to use the funds to accelerate:the development of its genetic tools and technologies including software, wetware, and artificial wombs to advance species preservation and restoration as well as further developing human genetic technologies, andhiring across computational biology, embryology, stem cell biology, software engineering, advanced biology, medical device hardware, and genomics.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Dallas, TX Undisclosed
USA

Phone

Undisclosed

Website

www.colossal.com

Email Address

Not Recorded

Overview

At Colossal Biosciences, we endeavor to jumpstart nature's ancestral heartbeat. To see the Woolly Mammoth thunder upon the tundra once again. To advance the economies of biology and nutrition. To make humanity more human. And to reawaken the lost wilds of Earth. So we, and our planet, can breathe easier.

Profile

Social Media

Colossal Biosciences Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Operating Officer

Kent Wakeford

Co-Founder

Brian Beard

Co-Founder

Andrew Busey

Co-Founder

Peter Phillips

Founder

George Church

Founder

Ben Lamm

Browse more venture capital transactions:

Prev: 3/9/2022: Audience Town venture capital transaction
Next: 3/9/2022: Silq venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary